Cargando…
Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
The incorporation of peripheral biomarkers in the treatment of major depressive disorders (MDD) could improve the efficiency of treatments and increase remission rate. Peripheral blood mononuclear cells (PBMCs) represent an attractive biological substrate allowing the identification of a drug respon...
Autores principales: | Mendez-David, Indira, Boursier, Céline, Domergue, Valérie, Colle, Romain, Falissard, Bruno, Corruble, Emmanuelle, Gardier, Alain M., Guilloux, Jean-Philippe, David, Denis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561647/ https://www.ncbi.nlm.nih.gov/pubmed/28860968 http://dx.doi.org/10.3389/fncel.2017.00237 |
Ejemplares similares
-
Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine
por: Lebeau, Rodolphe H., et al.
Publicado: (2022) -
A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatment
por: Mendez-David, Indira, et al.
Publicado: (2013) -
Learning and memory impairments in a neuroendocrine mouse model of anxiety/depression
por: Darcet, Flavie, et al.
Publicado: (2014) -
Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
por: Nguyen, Thi Mai Loan, et al.
Publicado: (2023) -
Ketamine and esketamine in suicidal thoughts and behaviors: a
systematic review
por: Jollant, Fabrice, et al.
Publicado: (2023)